For the Quarter Ending December 2025
Tenofovir Disoproxil Fumarate Prices in North America
- In United States, the Tenofovir Disoproxil Fumarate Price Index rose quarter-over-quarter in Q4 2025, influenced by rising input costs.
- Production costs increased in Q4 2025, driven by a 2.7% CPI rise in December 2025 and higher natural gas prices.
- A 3.0% PPI increase in November 2025 indicated higher manufacturing input costs for Tenofovir Disoproxil Fumarate.
- Demand for Tenofovir Disoproxil Fumarate was supported by a 2.0% industrial production increase in December 2025.
- Overall economic health, indicated by a 3.3% retail sales rise in November 2025, indirectly supported healthcare.
- US chemical product exports and imports both declined in October 2025, impacting overall trade flows.
- Global oil inventories increased in October and November 2025, reflecting broader commodity market trends.
- The Tenofovir Disoproxil Fumarate Price Index reflected persistent cost pressures during Q4 2025.
Why did the price of Tenofovir Disoproxil Fumarate change in December 2025 in North America?
- Rising input costs, including a 2.7% CPI increase in December 2025, pressured Tenofovir Disoproxil Fumarate prices.
- A 3.0% PPI increase in November 2025 indicated higher manufacturing input costs.
- Strengthening natural gas prices in December 2025 contributed to elevated production expenses.
Tenofovir Disoproxil Fumarate Prices in APAC
- In China, the Tenofovir Disoproxil Fumarate Price Index declined quarter-over-quarter in Q4 2025, influenced by easing production costs.
- Tenofovir Disoproxil Fumarate production costs decreased as the Producer Price Index fell by 1.9% in December 2025, reducing manufacturing input costs.
- Maleic Anhydride feedstock costs for fumaric acid production weakened in October 2025, significantly easing Tenofovir Disoproxil Fumarate production expenses.
- Demand for Tenofovir Disoproxil Fumarate faced mixed signals, with pharmaceutical sector demand sluggish in October 2025.
- China's Manufacturing Index expanded in December 2025, supporting the Tenofovir Disoproxil Fumarate supply chain efficiency.
- Industrial production grew by 5.2% in December 2025, ensuring stable raw material availability for manufacturing.
- Retail sales growth was a low 0.9% in December 2025, indirectly impacting overall healthcare market funding.
- Ample fumaric acid inventories in October 2025, alongside declining raw material stocks, influenced supply dynamics.
Why did the price of Tenofovir Disoproxil Fumarate change in December 2025 in APAC?
- Producer Price Index declined by 1.9% in December 2025, significantly reducing manufacturing input costs.
- Maleic Anhydride feedstock costs for fumaric acid production weakened in October 2025, easing production expenses.
- Manufacturing market demand showed mixed trends in Q4 2025, with pharmaceutical demand sluggish in October 2025.
Tenofovir Disoproxil Fumarate Prices in Europe
- In Germany, the Tenofovir Disoproxil Fumarate Price Index fell quarter-over-quarter in Q4 2025, influenced by contracting manufacturing activity in December 2025.
- Tenofovir Disoproxil Fumarate production costs faced upward pressure from a 1.8% CPI increase in December 2025, affecting operational expenses.
- Conversely, the Producer Price Index declined by 2.5% year-on-year in December 2025, indicating reduced input costs for producers.
- Demand outlook was challenged by a contracting Manufacturing Index and pessimistic consumer confidence (-17.5) in December 2025.
- Energy feedstock costs, including natural gas charges and carbon pricing, increased for 2025, impacting Tenofovir Disoproxil Fumarate production.
- Germany's industrial production grew by 0.8% year-on-year in October 2025, providing a stable, albeit slow, manufacturing environment.
- Retail sales increased by 1.1% year-on-year in November 2025, indirectly supporting the broader economic backdrop for healthcare.
- The Tenofovir Disoproxil Fumarate Price Forecast suggests continued pressure due to persistent weak economic sentiment in Germany.
Why did the price of Tenofovir Disoproxil Fumarate change in December 2025 in Europe?
- Contracting Manufacturing Index in December 2025 signaled weaker industrial activity, impacting overall market demand.
- Producer Price Index declined by 2.5% year-on-year in December 2025, reducing input costs for manufacturers.
- Increased natural gas costs and carbon pricing for 2025 exerted upward pressure on production expenses.
For the Quarter Ending September 2025
North America
- In the US, Tenofovir Disoproxil Fumarate Price Index rose Q3 2025, driven by increasing production costs.
- Production costs increased from 2.6% PPI rise in August 2025 and 3.0% CPI in September 2025.
- Robust demand for HIV and Hepatitis B treatments supported Tenofovir Disoproxil Fumarate in Q3 2025.
- Tenofovir Disoproxil Fumarate Price Forecast suggests upward pressure from rising input costs and strong demand.
- Fumaric acid feedstock costs declined in Q3 2025 due to lower freight costs and ample inventories.
- US retail sales increased 5.42% in September 2025, supporting healthcare funding and TDF demand.
- Low 4.3% unemployment rate in September 2025 enhanced healthcare access, positively impacting TDF demand.
- Industrial production rose 0.1% in September 2025, while consumer confidence declined to 94.2.
Why did the price of Tenofovir Disoproxil Fumarate change in September 2025 in North America?
- Producer prices increased 2.6% in August 2025, elevating Tenofovir Disoproxil Fumarate production expenses.
- Robust demand for HIV and Hepatitis B treatments supported Tenofovir Disoproxil Fumarate pricing in Q3 2025.
- US tariffs on pharmaceutical imports in July-September 2025 directly raised manufacturing costs.
Europe
- In Germany, the Tenofovir Disoproxil Fumarate Price Index fell quarter-over-quarter in Q3 2025, influenced by softening feedstock costs.
- Production costs for Tenofovir Disoproxil Fumarate trended lower, with propylene, fumaric acid, and naphtha prices weakening in Q3 2025.
- The Manufacturing Index contracted in Q3 2025, signaling a slowdown in industrial activity impacting supply chains.
- Industrial production declined 1.0% year-over-year in September 2025, affecting raw material availability and costs.
- The Producer Price Index decreased 1.7% year-over-year in September 2025, reducing pharmaceutical manufacturing expenses.
- Ample fumaric acid inventories in Q3 2025 contributed to downward pressure on intermediate chemical prices.
- The Consumer Price Index rose 2.4% year-over-year in September 2025, indicating broader inflationary pressures on operational costs.
- The Tenofovir Disoproxil Fumarate price outlook indicates stability or slight declines, driven by cost reductions and ample inventories.
Why did the price of Tenofovir Disoproxil Fumarate change in September 2025 in Europe?
- Softening propylene, fumaric acid, and naphtha feedstock costs significantly reduced production expenses in Q3 2025.
- The Producer Price Index fell 1.7% year-over-year in September 2025, directly lowering manufacturing costs.
- Ample fumaric acid inventories in Q3 2025 contributed to increased supply and downward pressure on intermediate prices.
APAC
- In China, Tenofovir Disoproxil Fumarate prices fell in Q3 2025, due to declining production costs and soft demand.
- Production costs declined, with the Producer Price Index (PPI) falling 2.3% year-on-year in September 2025.
- Fumaric acid feedstock costs decreased in China during Q3 2025, driven by sluggish demand and oversupply.
- Propylene feedstock supply significantly exceeded local demand in 2025, further easing Tenofovir Disoproxil Fumarate production expenses.
- Domestic consumer demand remained soft in Q3 2025, as the Consumer Price Index (CPI) declined 0.3% year-on-year.
- Consumer confidence was pessimistic at 89.6 in September 2025, indirectly impacting healthcare spending and patient access.
- Industrial production grew 6.5% year-on-year in September 2025, despite a contracting Manufacturing Index.
- Elevated overall chemical inventories in China during 2025, including high fumaric acid stocks, contributed to oversupply.
- China's chemical overcapacity impacted global supply chains, increasing competition and downward price pressure.
Why did the price of Tenofovir Disoproxil Fumarate change in September 2025 in APAC?
- The Producer Price Index (PPI) fell 2.3% year-on-year in September 2025, reducing Tenofovir Disoproxil Fumarate production costs.
- The Consumer Price Index (CPI) declined 0.3% year-on-year in September 2025, reflecting soft domestic demand.
- High fumaric acid inventories and overall chemical overcapacity in Q3 2025 contributed to downward price pressure.
